Menu
GeneBe

rs559836164

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_014625.4(NPHS2):c.124G>A(p.Gly42Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000596 in 1,516,052 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G42G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0034 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 2 hom. )

Consequence

NPHS2
NM_014625.4 missense

Scores

1
3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:3

Conservation

PhyloP100: -0.311
Variant links:
Genes affected
NPHS2 (HGNC:13394): (NPHS2 stomatin family member, podocin) This gene encodes a protein that plays a role in the regulation of glomerular permeability. Mutations in this gene cause steroid-resistant nephrotic syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006454259).
BP6
Variant 1-179575741-C-T is Benign according to our data. Variant chr1-179575741-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 550771.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NPHS2NM_014625.4 linkuse as main transcriptc.124G>A p.Gly42Arg missense_variant 1/8 ENST00000367615.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NPHS2ENST00000367615.9 linkuse as main transcriptc.124G>A p.Gly42Arg missense_variant 1/81 NM_014625.4 P1Q9NP85-1
NPHS2ENST00000367616.4 linkuse as main transcriptc.124G>A p.Gly42Arg missense_variant 1/71 Q9NP85-2

Frequencies

GnomAD3 genomes
AF:
0.00343
AC:
521
AN:
152050
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0119
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00151
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00192
GnomAD3 exomes
AF:
0.000794
AC:
90
AN:
113346
Hom.:
1
AF XY:
0.000633
AC XY:
40
AN XY:
63148
show subpopulations
Gnomad AFR exome
AF:
0.0175
Gnomad AMR exome
AF:
0.00115
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000102
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000582
GnomAD4 exome
AF:
0.000280
AC:
382
AN:
1363896
Hom.:
2
Cov.:
31
AF XY:
0.000254
AC XY:
171
AN XY:
673002
show subpopulations
Gnomad4 AFR exome
AF:
0.0101
Gnomad4 AMR exome
AF:
0.000966
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000919
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000748
Gnomad4 OTH exome
AF:
0.000723
GnomAD4 genome
AF:
0.00342
AC:
521
AN:
152156
Hom.:
4
Cov.:
32
AF XY:
0.00296
AC XY:
220
AN XY:
74386
show subpopulations
Gnomad4 AFR
AF:
0.0118
Gnomad4 AMR
AF:
0.00150
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00190
Alfa
AF:
0.00126
Hom.:
0
Bravo
AF:
0.00385
ExAC
AF:
0.000584
AC:
53

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nephrotic syndrome, type 2 Benign:2
Likely benign, criteria provided, single submitterclinical testingCounsylFeb 17, 2017- -
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Steroid-resistant nephrotic syndrome Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Apr 03, 2020- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 30, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
-0.010
Cadd
Benign
1.3
Dann
Benign
0.87
DEOGEN2
Benign
0.17
T;.
Eigen
Benign
-0.97
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.047
N
LIST_S2
Benign
0.45
T;T
MetaRNN
Benign
0.0065
T;T
MetaSVM
Pathogenic
1.3
D
MutationAssessor
Benign
1.0
L;L
MutationTaster
Benign
1.0
N;N
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.12
N;N
REVEL
Uncertain
0.56
Sift
Benign
0.049
D;D
Sift4G
Benign
0.36
T;T
Polyphen
0.0
B;B
Vest4
0.65
MutPred
0.72
Gain of MoRF binding (P = 0.013);Gain of MoRF binding (P = 0.013);
MVP
0.83
MPC
0.31
ClinPred
0.0044
T
GERP RS
0.75
Varity_R
0.053
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs559836164; hg19: chr1-179544876; API